Cetera Investment Advisers’s ASA Gold and Precious Metals ASA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.75M Sell
129,742
-372
-0.3% -$23.3K 0.01% 1397
2026
Q1
$8.07M Sell
130,114
-52,401
-29% -$3.54M 0.01% 1193
2025
Q4
$10.9M Sell
182,515
-3,837
-2% -$195K 0.01% 974
2025
Q3
$8.53M Buy
186,352
+72
+0% +$2.61K 0.01% 1085
2025
Q2
$5.88M Sell
186,280
-2,575
-1% -$78.7K 0.01% 1089
2025
Q1
$5.69M Buy
188,855
+130,547
+224% +$3.24M 0.01% 1032
2024
Q4
$1.18M Buy
58,308
+1,500
+3% +$31.2K ﹤0.01% 2052
2024
Q3
$1.18M Buy
+56,808
New +$1.1M ﹤0.01% 2007
2022
Q3
Sell
-10,950
Closed -$161K 1731
2022
Q2
$161K Hold
10,950
﹤0.01% 1688
2022
Q1
$245K Hold
10,950
﹤0.01% 1587
2021
Q4
$231K Buy
+10,950
New +$228K ﹤0.01% 1644

Other funds holding ASA

Cetera Investment Advisers's ASA Position: Q2 2026 in Review

Cetera Investment Advisers reduced its ASA Gold and Precious Metals (ASA) stake by 0.29% in Q2 2026, selling an estimated $23.3K and leaving 129,742 shares worth $6.75M. The position accounts for 0.01% of the portfolio, ranked #1397.

Cetera Investment Advisers first reported a position in ASA in Q4 2021 and has held it in 11 quarters since. The position peaked at $10.9M in Q4 2025. 74 funds tracked by Wall St. Rank hold ASA as of Q2 2026.

  • Cetera Investment Advisers held 129,742 shares of ASA Gold and Precious Metals worth $6.75M as of Q2 2026.
  • Cetera Investment Advisers sold 372 ASA Gold and Precious Metals shares in Q2 2026, an estimated $23.3K.
  • ASA Gold and Precious Metals made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1397 holding.
  • Cetera Investment Advisers first reported a position in ASA Gold and Precious Metals in Q4 2021 and has held it in 11 quarters since.
  • Cetera Investment Advisers's ASA Gold and Precious Metals position peaked at $10.9M in Q4 2025.
  • 74 funds tracked by Wall St. Rank held ASA Gold and Precious Metals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.